U.S. Paper and Forestry Products Stock News

Sangamo Therapeutics recently reported detailed Phase 1/2 STAAR study results for its Fabry disease gene therapy, isaralgagene civaparvovec, and confirmed a rolling Biologics License Application submission to the FDA under the Accelerated Approval pathway, supported by kidney function as an intermediate clinical endpoint. The company paired these clinically promising data and regulatory progress with a roughly US$24.82 million follow-on equity raise and a finance leadership change,...

In late January 2026, Microsoft reported fiscal Q2 results with revenue of US$81.27 billion and net income of US$38.46 billion, alongside record cloud revenue and the launch of its Maia 200 AI inference chip. Investors, however, fixated on moderating Azure growth, a very large US$37.50 billion AI‑driven capital spending bill, and heavy exposure to OpenAI within a US$625 billion cloud backlog, sparking concern about how quickly these AI bets will translate into durable returns. Next, we’ll...

Ardelyx (ARDX) has drawn fresh attention after securing a new US patent that extends protection for its tenapanor formulations, IBSRELA and XPHOZAH, to 2042, while also advancing IBSRELA into a Phase 3 trial in chronic idiopathic constipation. See our latest analysis for Ardelyx. Ardelyx’s recent patent win and progress with the ACCEL Phase 3 trial come after a strong run, with a 30-day share price return of 25.85% and a 1-year total shareholder return of 40.22%, alongside a small pullback...

If you are looking at Globus Medical and wondering whether the current share price lines up with its underlying worth, this article is built to walk you through that question step by step. The stock recently closed at US$87.45, with returns of 4.9% decline over 7 days, 0.2% over 30 days, 0.2% year to date, 5.1% decline over 1 year, 12.3% over 3 years, and 34.9% over 5 years, which may shape how investors think about both its potential and its risks. Recent news coverage around Globus Medical...

Labcorp Holdings (NYSE:LH) has amended its receivables purchase agreement, extending the facility’s termination date. The amendment adds an accordion feature that can increase borrowing capacity under certain conditions. The revised structure is intended to provide greater liquidity flexibility for the company’s operations and planning. Labcorp is a large diagnostics and laboratory services provider, so reliable access to funding is important for supporting day to day testing volumes and...

IDEX Corporation reported its latest quarterly results on Wednesday, with analysts having expected modest year-on-year revenue growth following a prior quarter in which the company exceeded revenue and operating income estimates. Investors are also watching IDEX’s long record of paying and raising dividends, supported by profitability and financial stability that underpin its capital-return approach. Next, we’ll examine how anticipation around the earnings release and IDEX’s dividend track...

Why Central Bancompany is on investors’ radar today Central Bancompany (CBC) is drawing attention after a recent move in its share price, with the stock closing at $24.50 and showing varied returns over the past day, week, month, and past 3 months. See our latest analysis for Central Bancompany. While the 1 day share price return shows a 1.61% pullback to $24.50, the 90 day share price return of 15.29% sits alongside a 1 year total shareholder return of 89.00%. Together, these figures point...

If you are wondering whether WeRide's current share price offers value or just fresh risk, you are not alone. This article is going to focus squarely on what the numbers are saying about its valuation. WeRide's shares last closed at US$7.58, with returns of 14.3% decline over the past week, 19.3% decline over the past month, and 48.0% decline over the last year. This raises fair questions about how the market is currently pricing the stock. Recent news around autonomous driving regulation,...

Flowco Holdings (NYSE:FLOC) entered a definitive agreement to acquire the parent company of Valiant Artificial Lift Solutions. The deal expands Flowco Holdings' artificial lift portfolio within the energy sector. The transaction represents a material corporate development for investors tracking NYSE:FLOC. For you as an investor, this move adds another piece to the story of Flowco Holdings, an artificial lift and production optimization player within the energy industry. The company is...

HF Sinclair, ticker NYSE:DINO, has agreed to acquire Industrial Oils Unlimited to expand its lubricants and specialty fluids business. The deal is framed by management as a way to build scale and product breadth in a key non fuels segment. The acquisition adds another element to HF Sinclair's broader portfolio of refinery and downstream operations. HF Sinclair enters this deal with its shares at $54.63 and a 1 year return of 51.2%, alongside a 5 year return of 104.2%. The stock has also...

If you are wondering whether Five9's current share price reflects its true worth, you are not alone. This article will walk through the key numbers that matter for valuation. Five9's share price closed at US$16.71, with returns of a 9% decline over 7 days, an 11.2% decline over 30 days, an 11.2% decline year to date, a 60.8% decline over 1 year, an 80.2% decline over 3 years and a 90.6% decline over 5 years, which naturally raises questions about both risk and potential. Recent coverage has...

If you are wondering whether UniFirst at around US$203 is a fair deal or a stretch, you are not alone. This article is built to help you frame that question clearly. The stock has seen mixed returns, with a 4.9% gain over the past month and year to date, against a 3.2% decline over the last 7 days and an 8% decline over the past year. These moves may have shifted how some investors view its potential and risks. Recent coverage around UniFirst has largely focused on the company as a long...

Alphabet recently moved to dramatically expand its footprint in India, securing rights to up to 2.4 million square feet of office space in Bengaluru that could house as many as 20,000 additional employees, while its Waymo unit raised US$16 billion at a US$126 billion valuation and investors looked ahead to Q4 2025 earnings. Together, the India build-out, Waymo funding, and Gemini- and cloud-focused expectations highlight how Alphabet is tying long-term AI and autonomous-mobility ambitions to...

Oracle (NYSE:ORCL) is planning a capital raise of about US$45b to US$50b to fund a large-scale buildout of its AI-focused cloud infrastructure. The funding mix is expected to include both new debt and equity, linked to demand from major AI clients such as OpenAI and Nvidia. The company is also reported to be preparing significant workforce reductions and considering a sale of its healthcare software unit, Cerner. Oracle operates at the intersection of enterprise software, databases and...

Fabrinet (FN) kicked off Q2 2026 with revenue of about US$1.1b and basic EPS of US$3.14, putting fresh numbers on the board for investors tracking its earnings story. The company has seen quarterly revenue move from US$833.6m in Q2 2025 to US$1.1b in Q2 2026, while basic EPS over that same period shifted from US$2.40 to US$3.14, with trailing twelve month EPS at US$10.52. With net income and margins now in clearer view, the latest print gives investors more to work with on how sustainable its...

Dividend recovery and portfolio reshaping at W. P. Carey W. P. Carey (WPC) is back in focus after cutting its dividend in late 2023, then raising it for eight straight quarters while cycling US$1.5b of dispositions into US$2.1b of new properties. See our latest analysis for W. P. Carey. At a share price of US$69.25, W. P. Carey has seen a 6.77% year to date share price return and a 32.80% one year total shareholder return. This suggests that recent dividend progress and portfolio reshaping...

If you are wondering whether Guardant Health at US$113.05 is starting to look expensive or still offers value, you are not alone in asking that question right now. The stock has seen a 1.3% decline over the last 7 days, an 11.1% return over the last 30 days and year to date, a 139.7% return over the last year, a 295.8% return over 3 years, and a 30.8% decline over 5 years. This may suggest the market’s view of its risk and potential has shifted over different time frames. Recent coverage has...

A nationwide class action lawsuit accuses Costco of falsely marketing its Kirkland Signature Rotisserie Chicken as “no preservatives.” Plaintiffs claim the product contains additives that function as preservatives, allegedly misleading millions of shoppers across the United States. The case raises questions about Costco’s labeling practices and potential exposure under consumer protection laws. Costco Wholesale, traded as NasdaqGS:COST, is widely known for its membership warehouse model and...

BlackRock, through its Global Infrastructure Partners arm, is reported to be exploring a joint acquisition of U.S. utility AES alongside EQT AB. In India, Jio BlackRock has launched an AI powered digital investment advisory platform aimed at expanding access to financial products. BlackRock has disclosed an increased stake in European company Syensqo, crossing a regulatory reporting threshold. NYSE:BLK is trading around $1,070.08, with a 1 year return of 7.5% and longer term gains of 55.3%...

Lockheed Martin (LMT) just combined a strong fourth quarter, a higher 2026 outlook for sales and profit, and major interceptor production agreements into one dense batch of information for investors. See our latest analysis for Lockheed Martin. The 26.4% year to date share price return, including a 26.4% 1 month share price return and 32.8% 3 month share price return, suggests strong momentum. The 42.6% 1 year total shareholder return and 110.6% 5 year total shareholder return indicate that...

IDEXX Laboratories (IDXX) is back in focus after reporting fourth quarter and full year 2025 results that topped analyst expectations, paired with fresh 2026 guidance outlining revenue and earnings growth targets. See our latest analysis for IDEXX Laboratories. Despite the upbeat fourth quarter and 2026 outlook, IDEXX Laboratories’ recent share price performance has cooled. The 7 day share price return is 8.95% and the 90 day share price return is 12.17%, set against a 1 year total...

Tencent Music Entertainment Group (NYSE:TME) has formed a new joint venture called ONECEAD with CJ ENM and JYP China. The partnership focuses on developing, launching and managing next generation artists for global audiences. ONECEAD is intended to combine music production, artist management and content distribution capabilities across China, Korea and international markets. For investors watching NYSE:TME, this move comes with the stock at $16.4 and a 1 year return of 38.2%. Over 3 years,...

If you are wondering whether ADMA Biologics at US$17.52 still offers value or has already run too far, this breakdown will help you put the current share price in context. The stock has had mixed returns, with a 7.3% gain over the last week, a 2.8% decline over the last month, a 2.0% decline year to date, a 3.9% return over the past year, and a very large return over three and five years. Recent coverage of ADMA Biologics has focused on its share price performance over different time frames,...

Coty recently announced a collaboration with OpenAI to roll out ChatGPT Enterprise across selected parts of its global organization, aiming to support employees’ daily work, creativity and cross‑functional collaboration with enterprise-grade AI tools. This move positions Coty as an early adopter of advanced AI within the beauty industry, potentially reshaping how it manages innovation, efficiency and internal decision-making. We will now examine how Coty’s adoption of ChatGPT Enterprise...